At the center of the U.S. government’s argument is the accusation that, rather than being a young, ambitious tech visionary who simply failed to pull off her dreams, Holmes crossed the line into outright fraud, misleading investors, business partners and the media about the blood-testing machines her company was trying to develop. She ultimately did it to save her faltering business, prosecutors alleged.
The Transform Technology Summits start October 13th with Low-Code/No Code: Enabling Enterprise Agility. Register now! More than half of companies are planning to move to